.jpg)
Nasdaq (Nasdaq: NDAQ) announced today the results of the semi-annual review of the OMX Stockholm Benchmark Index, (Nasdaq Stockholm: OMXSB), which will become effective at market open on Wednesday, December 1, 2021.
The following securities will be added to the Index:
| Addtech AB ser. B (ADDT B) | Lifco AB Ser. B (LIFCO B) |
| Africa Oil Corp. (AOI) | Mekonomen AB (MEKO) |
| Cibus Nordic Real Estate AB (CIBUS) | Stillfront Group AB (SF) |
| Cint Group AB (CINT) | Storskogen Group AB ser. B (STOR B) |
| CTEK AB (CTEK) | Troax Group AB (TROAX) |
| Dios AB (DIOS) | Truecaller AB ser. B (TRUE B) |
The following securities will be removed from the Index:
| Addnode Group AB ser. B (ANOD B) | Lundbergforetagen AB, L E ser. B (LUND B) |
| Camurus AB (CAMX) | Nobia AB (NOBI) |
| Eolus Vind AB, ser. B (EOLU B) | Oncopeptides AB (ONCO) |
| Etrion Corporation (ETX) | Nordnet AB (SAVE) |
| Hemnet Group AB (HEM) | Millicom International Cellular (TIGO SDB) |
| Hansa Biopharma AB (HNSA) | Xvivo Perfusion AB (XVIVO) |
The OMX Stockholm Benchmark Index measures the performance of a selection of the largest and most traded securities listed on Nasdaq Stockholm AB. The Index is reviewed semi-annually in June and December. For more information, please refer to the OMX Stockholm Benchmark Index Methodology.
